Gilead published New Data for the Treatment of HIV in Black Americans
The FINANCIAL -- Gilead Sciences, Inc. (Nasdaq: GILD) today announced 48-week data from the BRAAVE 2020 study, a Phase 3 ...
ADVERTISEMENT
Tag: Treatment of HIV of americans
ADVERTISEMENT
Popular Last 24h
-
Ampersand wins £22m five-year contract at London Zoo
-
Anurag Bajpayee’s Gradiant : The Water Tech Firm Rides Industrial Demand Toward Global Expansion
-
Priority Reports Record Growth Under Thomas Priore’s Leadership, With EBITDA Soaring 21% in 2024
-
Irnero’s Innovative Solution for Contaminated Air in Public Places and Transport
-
What Are the Income Limits for Deducting Traditional IRA Contributions in 2025?
-
Boost Your Online Presence:
-
Eshvi Signals The Beginning of a Bold New Era by Opening A New Location
LATEST POSTS
LATESTINTERVIEWS
ADVERTISEMENT
